Cite

HARVARD Citation

    Forsythe, A. et al. (n.d.). 254PMatching-adjusted indirect treatment comparison of ribociclib and palbociclib as first-line treatments for HR+, HER2– ABC. Annals of oncology. p. . [Online]. 
  
Back to record